RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to 4.6 cmyear in Children 5 Years of Age and Older in the Low Dose Cohort
| LSIRX Fund | USD 46.66 0.28 0.60% |
Slightly above 52% of Clearbridge Mid's investor base is interested to short. The analysis of overall sentiment of trading Clearbridge Mid Cap mutual fund suggests that many investors are impartial at this time. Clearbridge Mid's investing sentiment can be driven by a variety of factors including economic data, Clearbridge Mid's earnings reports, geopolitical events, and overall market trends.
Clearbridge |
TOKYO, November 05, 2024--RIBOMIC, Inc. , a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has been conducting a Phase IIa clinical trial of umedaptanib pegol in pediatric patients with achondroplasia , and today announces that the administration of the low-dose subcutaneous injection group has been completed and demonstrated a positive impact of the test drug on the pati
Read at finance.yahoo.com
 |
Clearbridge Mid Fundamental Analysis
We analyze Clearbridge Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearbridge Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearbridge Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Clearbridge Mid is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Clearbridge Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearbridge Mid mutual fund to make a market-neutral strategy. Peer analysis of Clearbridge Mid could also be used in its relative valuation, which is a method of valuing Clearbridge Mid by comparing valuation metrics with similar companies.
Peers
Clearbridge Mid Related Equities
| SSMMX | Western Asset | 0.46 | ||||
| WAASX | Western Asset | 0.44 | ||||
| SAPCX | Clearbridge Appreciation | 0.36 | ||||
| SAGCX | Clearbridge Aggressive | 0.22 | ||||
| WACIX | Western Asset | 0.11 | ||||
| LGOCX | Legg Mason | 0.48 | ||||
| LGSCX | Qs Small | 0.57 | ||||
| LGASX | Clearbridge Small | 0.64 | ||||
| LGFEX | Qs International | 0.65 | ||||
| WACSX | Western Asset | 0.66 |
Other Information on Investing in Clearbridge Mutual Fund
Clearbridge Mid financial ratios help investors to determine whether Clearbridge Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clearbridge with respect to the benefits of owning Clearbridge Mid security.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |